The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Clark James David since 2019.
This trader's CIK number is 1757584.
At the time of last reporting, Clark James David was the SVP, Cont & Chief Acct Officer of Cvs Health Corp. (stock ticker symbol CVS).
Also see all insider trading activities at Cvs Health Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CVS | 0 | $0 | 7,513 | $498,487 | 7,513 | $467,383 |
| 2023 | CVS | 0 | $0 | 25,759 | $1,928,447 | 0 | $0 |
| 2022 | CVS | 0 | $0 | 6,059 | $660,431 | 6,059 | $619,593 |
| 2021 | CVS | 0 | $0 | 5,350 | $406,600 | 5,350 | $397,451 |
| 2020 | CVS | 0 | $0 | 9,534 | $604,560 | 3,030 | $165,225 |
| 2019 | CVS | 0 | $0 | 1,664 | $96,744 | 1,664 | $74,996 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-05 | CVS | Option Ex | 7,513 | 62.21 | 467,383 |
| 2025-03-05 | CVS | Sale | 7,513 | 66.35 | 498,487 |
| 2023-08-03 | CVS | Sale | 25,759 | 74.86 | 1,928,447 |
| 2022-01-28 | CVS | Option Ex | 6,059 | 102.26 | 619,593 |
| 2022-01-28 | CVS | Sale | 6,059 | 109.00 | 660,431 |
| 2021-03-31 | CVS | Option Ex | 5,350 | 74.29 | 397,451 |
| 2021-03-31 | CVS | Sale | 5,350 | 76.00 | 406,600 |
| 2020-05-26 | CVS | Sale | 270 | 65.00 | 17,550 |
| 2020-04-28 | CVS | Sale | 6,234 | 65.00 | 405,210 |
| 2020-03-30 | CVS | Option Ex | 3,030 | 54.53 | 165,225 |
| 2020-03-30 | CVS | Sale | 3,030 | 60.00 | 181,800 |
| 2019-03-01 | CVS | Sale | 1,664 | 58.14 | 96,744 |
| 2019-03-01 | CVS | Option Ex | 1,664 | 45.07 | 74,996 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clark James David (SVP, Cont & Chief Acct Officer of Cvs Health Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.